Skip to main content
. 2022 Sep 14;14(18):3781. doi: 10.3390/nu14183781

Table 1.

Baseline characteristics of women participating in the DALI Vitamin D trial.

Vitamin D
N = 79
Placebo N = 75 p Total N = 154 Excluded N = 33 p
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age (year) 32.8 (5.4) 32.2 (5.2) ns 32.5 (5.3) 33.5 (4.6) ns
Height (cm) 165.1 (6.6) 164.7 (7.4) ns 164.9 (7.0) 163.2 (4.9) ns
Pre-pregnancy weight (kg) 92.0 (13.8) 90.3 (13.4) ns 91.2 (13.7) 91.4 (16.1) ns
Pre pregnancy BMI (kg/m2) 33.7 (4.3) 33.3 (4.3) ns 33.5 (4.3) 34.3 (6.0) ns
Weight gain until 1st visit (kg) 2.3 (4.8) 1.3 (3.4) ns 1.8 (4.2) 2.4 (3.5) ns
Gestational week at enrollment (weeks) 15.0 (2.9) 15.4 (2.5) ns 15.2 (2.7) 15.3 (2.8) ns
N (%) N (%) N (%) N (%)
European descent 72/79 (91.1) 59/75 (78.7%) <0.05 131/154 (85.1) 30/33 (90.9) ns
Higher education 50/78 (64.1) 45/75 (60.0) ns 95/153 (62.1) 18/33 (54.5) ns
Multiparity 48/79 (60.8) 46/75 (61.3) ns 94/154 (61.0) 21/33 (63.6) ns
Diabetes in family 12/79 (15.2) 17/75 (22.7) ns 29/154 (18.8) 11/32 (34.4) ns
History of GDM 7/46 (15.2) 7/46 (15.2) ns 14/92 (15.2) 4/19 (21.1) ns
Previous unexplained stillbirth 5/45 (13.3) 3/46 (6.5) ns 9/91 (9.9) 2/19 (10.5) ns
History of malformation 4/47 (8.5) 1/45 (2.2) ns 5/92 (5.4) 1/19 (5.2) ns
Prev. macrosomia 15/47 (31.9) 11/46 (23.9) ns 26/93 (28.0) 6/19 (31.6) ns
PCOS 10/79 (12.7) 11/74 (14.9) ns 21/153 (13.7) 6/33 (18.2) ns
Chronic hypertension 14/79 (17.7) 9/74 (12.2) ns 23/153 (15.0) 7/33 (21.1) ns
Smoking 17/79 (22.5) 14/75 (18.7 ns 31/154 (20.1) 7/33 (21.2) ns
Alcohol in pregnancy 6/76 (7.9 5/74 (6.8) ns 11/150 (7.3) 2/33 (6.1) ns
Taking pregnancy vitamins 68/79 (86.1%) 63/75 (84.0%) ns 131/154 (85.1) 32/33 (97.0) ns
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
BP sys (mmHg) 115.6 (11.6) 114.9 (12.0) ns 115.2 (11.7) 118.9 (11.2) ns
BP dia (mmHg) 72.4 (9.3) 71.4 (9.2) ns 71.9 (9.2) 75.0 (8.6) ns
Heart rate (bpm) 79.2 (10.3) 79.1 (9.7) ns 79.2 (10.0) 82.4 (11.7) ns
Triglycerides (mmol/L) 1.32 (0.41) 1.41 (0.55) ns 1.36 (0.48) 1.40 (0.64) ns
LDL-C (mmol/L) 3.21 (0.72) 2.96 (0.73) <0.05 3.08 (0.74) 3.04 (0.70) ns
HDL-C (mmol/L) 1.37 (0.23) 1.33 (0.28) ns 1.35 (0.26) 1.40 (0.22) ns
FFA (mmol/L) 0.62 (0.23) 0.64 (0.29) ns 0.64 (0.26) 0.68 (0.22) ns
3BHB (mmol/L) 0.067 (0.085) 0.057 (0.074) ns 0.062 (0.080) 0.087 (0.096) ns
Leptin (ng/dL) 34.5 (17.6) 33.7 (17.6) ns 34.0 (17.1) 36.9 (20.3) ns
Calcium (mmol/L) 2.2 (0.3) 2.2 (0.4) ns 2.2 (0.3) 2.3 (0.1) ns
Albumin (g/L) 36.5 (3.6) 36.1 (3.9) ns 36.3 (3.8) 37.0 (4.5) ns
Albumin-corrected Calcium (mmol/L) 2.2 (0.3) 2.2 (0.4) ns 2.2 (0.4 2.3 (0.1) ns
25OH D2 (nmol/L) 4.2 (4.6) 3.0 (4.3) ns 3.6 (4.5) 3.6 (4.6) ns
25OH D3 (nmol/L) 69.3 (26.8) 66.7 (26.8) ns 68.0 (26.7) 63.3 (25.4) ns
25OH D total (nmol/L) 73.40 (26.8) 69.8 (26.9) ns 71.6 (26.8) 66.9 (25.9) ns
Skinfold biceps (mm) 20.1 (7.9) 19.8 (6.4) ns 20.0 (7.2) 17.1 (7.2) <0.05
Skinfold triceps (mm) 28.2 (6.6) 28.1 (6.0) ns 28.1 (6.3) 26.9 (5.7) ns
Skinfold subscapular (mm) 28.6 (7.4) 30.3 (9.4) ns 29.4 (8.4) 30.5 (6.8) ns
Skinfold supra-iliac (mm) 34.3 (7.8) 33.3 (8.8) ns 33.8 (8.3) 31.8 (7.1) ns
Sum of skinfolds (mm) 111.3 (20.5) 111.5 (24.2) ns 111.4 (22.3) 106.3 (19.6) ns
Fat percentage (%) 31.1 (2.9) 31.2 (3.2) ns 31.1 (3.0) 30.8 (2.3) ns
Neck circumference (cm) 36.3 (2.3) 36.4 (2.0) ns 36.4 (2.2) 36.6 (2.6) ns

SD = standard deviation, p = level of significance, ns = not significant, BMI = body mass index, GDM = gestational diabetes mellitus, PCOS = polycystic ovary syndrome, BP = blood pressure, sys = systolic, dia = diastolic, bpm = beats per minute, LDL-C = Low Density Lipoprotein cholesterol, HDL-C = High Density Lipoprotein cholesterol, FFA = free fatty acid, 3BHB = beta-hydroxy butyrate, 25OH D = 25 hydroxyvitamin.